165 results on '"Bhadri, Vivek"'
Search Results
2. High-dose chemotherapy for Ewing sarcoma and Rhabdomyosarcoma: A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party
3. Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial
4. Effect of Radiotherapy Dose on Outcome in Nonmetastatic Ewing Sarcoma
5. High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008.
6. Diagnosis and management of phyllodes tumours for the surgeon: An algorithm
7. Extrapleural pneumonectomy for sarcoma: Outcomes of adult patients at a specialized center
8. Factors Influencing the Outcome of Patients with Primary Ewing Sarcoma of the Sacrum
9. Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
10. Supplementary Figure S2 from Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial
11. Supplementary Data S2 from Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial
12. Supplementary Table S5 from Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial
13. Study Protocol S1 from Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial
14. Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial
15. Zoledronic acid add-on therapy for standard-risk Ewing sarcoma patients in the Ewing 2008R1 trial
16. Extrapleural pneumonectomy for sarcoma: outcomes of adult patients at a specialized center and literature review.
17. Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells
18. High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma
19. Abstract CT177: SQ3370 in advanced solid tumors: Interim phase 1 results
20. Interim phase 1 results for SQ3370 in advanced solid tumors.
21. Value of adjuvant radiotherapy in patients with localized Ewing sarcoma at the extremities: Report from the Ewing 2008 trial.
22. Mesenchymal chondrosarcoma: An Australian multi‐centre cohort study
23. High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma.
24. Metastatic osteosarcoma bowel perforation secondary to chemotherapy-induced tumour necrosis
25. Left cheek sclerosing rhabdomyosarcoma and development of isolated free flap donor site metastasis
26. Systemic treatments and outcomes inCIC‐rearranged Sarcoma: A national multi‐centre clinicopathological series and literature review
27. 367 Pharmacokinetic and immunologic data from a phase I study of the click chemistry-based therapy SQ3370 in advanced solid tumors and soft-tissue sarcoma provides proof-of-concept for the CAPAC platform
28. Re: Efficacy and safety of regorafenib in patients with metastatic or locally-advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study
29. Mesenchymal chondrosarcoma: An Australian multi‐centre cohort study.
30. Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition
31. Abstract CT225: Phase 1 trial of SQ3370 in solid tumors
32. Value of Zolendronic Acid Maintenance Therapy in Patients With Standard Risk Localized Ewing Sarcoma : Report From the International Ewing 2008 Trial
33. PD ‐1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma
34. 416 SQ3370–001 is a multi-center open-label phase I dose-escalation study to test a novel intratumoral and systemic approach to treat advanced solid tumors
35. Systemic treatments and outcomes in CIC‐rearranged Sarcoma: A national multi‐centre clinicopathological series and literature review.
36. Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia
37. Excellent response to dasatinib of childhood Philadelphia positive intracranial acute lymphoblastic leukaemia tumours
38. Mesenchymal chondrosarcoma: An Australian multi-centre cohort study.
39. High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008.
40. Evaluation of the NOD/SCID xenograft model for glucocorticoid-regulated gene expression in childhood B-cell precursor acute lymphoblastic leukemia
41. PD‐1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma.
42. FISH analysis of selected soft tissue tumors: Diagnostic experience in a tertiary center
43. PD-1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma.
44. FISH analysis of selected soft tissue tumors: Diagnostic experience in a tertiary center.
45. Atypical Ewing sarcoma breakpoint region 1 fluorescencein-situhybridization signal patterns in bone and soft tissue tumours: diagnostic experience with 135 cases
46. Programmed cell death-1 blockade in recurrent disseminated Ewing sarcoma
47. A phase 2, open-label, adaptive, dose-ranging study with long-term extension to evaluate the safety, tolerability, efficacy, and pharmacokinetics of intra-articular AMB-05X injections in patients with tenosynovial giant cell tumor.
48. Glucocorticoid resistance in childhood B-Cell precursor acute lymphoblastic leukaemia
49. Stability of gene expression and epigenetic profiles highlights the utility of patient-derived paediatric acute lymphoblastic leukaemia xenografts for investigating molecular mechanisms of drug resistance
50. Atypical Ewing sarcoma breakpoint region 1 fluorescence in-situ hybridization signal patterns in bone and soft tissue tumours: diagnostic experience with 135 cases.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.